Hakam Abu-Zahra
- Oncology top 5%
- Cancer Research top 5%
- Public Health, Environmental and Occupational Health top 10%
- General Health Professions top 10%
- Genetics
- Co-authors
- B. FindlayAndrew ArnoldMark N. LevineV. BramwellKathleen I. PritchardDavid WarrTed VandenbergRobert G. MacKenzie
- Topics
- Cancer Treatment and Pharmacology (5 papers)Breast Cancer Treatment Studies (5 papers)Acute Myeloid Leukemia Research (3 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Hakam Abu-Zahra
20 papers receiving 913 citations
Peers
Comparison fields: 5 of 106
- Oncology 551
- Cancer Research 413
- Public Health, Environmental and Occupational Health 152
- General Health Professions 143
- Genetics 110
Countries citing papers authored by Hakam Abu-Zahra
This map shows the geographic impact of Hakam Abu-Zahra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakam Abu-Zahra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakam Abu-Zahra more than expected).
Fields of papers citing papers by Hakam Abu-Zahra
This network shows the impact of papers produced by Hakam Abu-Zahra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakam Abu-Zahra. The network helps show where Hakam Abu-Zahra may publish in the future.
Co-authorship network of co-authors of Hakam Abu-Zahra
This figure shows the co-authorship network connecting the top 25 collaborators of Hakam Abu-Zahra. A scholar is included among the top collaborators of Hakam Abu-Zahra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakam Abu-Zahra. Hakam Abu-Zahra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 101 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 18 | |
| 5 | 185 | |
| 6 | 36 | |
| 7 | 442 | |
| 8 | 18 | |
| 9 | 5 | |
| 10 | 15 | |
| 11 | 47 | |
| 12 | 10 | |
| 13 | 14 | |
| 14 | 32 | |
| 15 | Treatment of acute myeloblastic leukemia in adults: remission induction with a combination of cyclophosphamide, cytarabine and vincristine. | 9 |
| 16 | The effect of remission induction in acute myeloblastic leukemia on efficiency of colony formation in culture. | 11 |
| 17 | Bone marrow transplantation in patients with acute leukaemia. | 4 |
| 18 | 6 | |
| 19 | 16 | |
| 20 | 2 |
About Hakam Abu-Zahra
Hakam Abu-Zahra is a scholar working on Cancer Research, Hematology and Oncology, having authored 20 papers that have together received 973 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (5 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Cancer Research (413 citations), Oncology (551 citations) and Chemical Health and Safety (5 citations). Hakam Abu-Zahra has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include B. Findlay, Andrew Arnold, Mark N. Levine, V. Bramwell, Kathleen I. Pritchard, David Warr, Ted Vandenberg, Robert G. MacKenzie, B. Norris and J Robert. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.